D-106-2013 Class II Terminated
FDA drug recall D-106-2013 was initiated by Hospira Inc. on Oct 25, 2012 and is designated Class II. Reason for recall: Presence of Particulates; may contain glass particles The recall status is terminated (terminated Oct 15, 2014). Affected quantity: 361,600/1-mL ampules.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 9, 2013
- Initiation Date
- Oct 25, 2012
- Termination Date
- Oct 15, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 361,600/1-mL ampules
Product Description
Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
Reason for Recall
Presence of Particulates; may contain glass particles
Distribution Pattern
Nationwide
Code Information
Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-106-2013
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026